Chemotherapy-treated human CAFs promoted cancer-initiating cell self-renewal via IL-17A, and IL-17A was found to be overexpressed in colorectal CAFs in response to chemotherapy, as validated directly in patient-derived specimens without culture [131]. This evidence concerns the gene IL17A and cancer.